Drugs / Platelet
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03045068 | Apr 2017 → Oct 2018 | cardiac rhythm disease, cardiac valvular defect | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03045068 ↗ |
| Route | Intravenous | “via a central venous line” NCT03045068 ↗ |